2026 Q2 Portfolio Activity
In 2026 Q2, Lion Point Capital, LP maintained a portfolio of 35 distinct positions. The fund also reduced its exposure to CUE BIOPHARMA INC by 97.6%.
Position History
hover any row below to update
Loading…
Total Positions
35
Quarter
2026 Q2
Top Holding
CUE (8.0%)
Top 10 Concentration
55.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-35 of 35
Lion Point Capital, LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CUE
CUE BIOPHARMA I...
|
Healthcare | 7.99% | 3.03% |
#1
11
Prev: #12
|
5.2 |
—
|
-2,149,926 | -97.6% |
P
S
|
52,928 | $1,670,408 |
$9.15
+166.2%
|
2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 7.13% | 8.57% |
#2
1
Prev: #1
|
5.4 |
—
|
no change | no change |
P
S
|
4,450 | $1,489,816 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 6.29% | 7.52% |
#3
1
Prev: #2
|
4.5 |
—
|
no change | no change |
P
S
|
67,500 | $1,314,225 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FENC
FENNEC PHARMACE...
|
Healthcare | 5.78% | 4.13% |
#4
4
Prev: #8
|
3.8 |
—
|
no change | no change |
P
S
|
112,434 | $1,208,666 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RPRX
ROYALTY PHARMA ...
|
Healthcare | 5.74% | 6.14% |
#5
2
Prev: #3
|
3.8 |
—
|
no change | no change |
P
S
|
21,400 | $1,199,898 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 5.41% | 2.64% |
#6
7
Prev: #13
|
3.2 |
—
|
no change | no change |
P
S
|
80,000 | $1,132,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MIST
MILESTONE PHARM...
|
Healthcare | 5.26% | 5.83% |
#7
3
Prev: #4
|
3.1 |
—
|
no change | no change |
P
S
|
820,000 | $1,098,800 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BNTC
BENITEC BIOPHAR...
|
Healthcare | 3.97% | 3.95% |
#8
1
Prev: #9
|
2.6 |
—
|
no change | no change |
P
S
|
62,000 | $829,560 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 3.76% | 5.03% |
#9
3
Prev: #6
|
2.5 |
—
|
no change | no change |
P
S
|
36,000 | $786,960 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 3.68% | 2.61% |
#10
4
Prev: #14
|
2.5 |
—
|
no change | no change |
P
S
|
51,700 | $769,296 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GERN
GERON CORP
|
Healthcare | 3.54% | 5.15% |
#11
6
Prev: #5
|
2.4 |
—
|
no change | no change |
P
S
|
578,000 | $739,840 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
UNIQURE NV
|
Healthcare | 3.24% | 1.44% |
#12
16
Prev: #28
|
2.3 |
—
|
no change | no change |
P
S
|
14,700 | $677,082 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 3.14% | 4.61% |
#13
6
Prev: #7
|
2.3 |
—
|
no change | no change |
P
S
|
128,650 | $656,115 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 2.92% | 2.49% |
#14
1
Prev: #15
|
2.2 |
—
|
no change | no change |
P
S
|
5,500 | $610,170 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 2.83% | 3.10% |
#15
4
Prev: #11
|
2.1 |
—
|
no change | no change |
P
S
|
8,100 | $592,434 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SRPT
SAREPTA THERAPE...
|
Healthcare | 2.45% | 3.71% |
#16
6
Prev: #10
|
2.0 |
—
|
no change | no change |
P
S
|
28,500 | $512,145 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HUMA
HUMACYTE INC
|
Healthcare | 2.43% | 2.36% |
#17
Prev: #17
|
2.0 |
—
|
no change | no change |
P
S
|
650,000 | $507,260 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 2.41% | 2.24% |
#18
1
Prev: #19
|
2.0 |
—
|
no change | no change |
P
S
|
46,000 | $504,620 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VTRS
VIATRIS INC
|
Healthcare | 2.10% | 2.24% |
#19
1
Prev: #18
|
1.8 |
—
|
no change | no change |
P
S
|
27,700 | $439,876 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.91% | 1.95% |
#20
1
Prev: #21
|
1.8 |
—
|
no change | no change |
P
S
|
18,000 | $399,780 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 1.78% | 2.22% |
#21
1
Prev: #20
|
1.7 |
—
|
no change | no change |
P
S
|
5,000 | $372,400 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.77% | 1.71% |
#22
2
Prev: #24
|
1.7 |
—
|
no change | no change |
P
S
|
9,100 | $369,733 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PCRX
PACIRA BIOSCIEN...
|
Healthcare | 1.64% | 1.82% |
#23
Prev: #23
|
1.7 |
—
|
no change | no change |
P
S
|
13,500 | $342,495 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RGNX
REGENXBIO INC
|
Healthcare | 1.52% | 1.33% |
#24
5
Prev: #29
|
1.6 |
—
|
no change | no change |
P
S
|
26,600 | $318,668 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RCKT
ROCKET PHARMACE...
|
Healthcare | 1.41% | 1.84% |
#25
3
Prev: #22
|
1.6 |
—
|
no change | no change |
P
S
|
86,000 | $294,120 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 1.40% | 1.58% |
#26
1
Prev: #27
|
1.6 |
—
|
no change | no change |
P
S
|
19,000 | $291,840 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 1.36% | 1.70% |
#27
2
Prev: #25
|
1.5 |
—
|
no change | no change |
P
S
|
10,500 | $283,290 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 1.31% | 0.86% |
#28
4
Prev: #32
|
1.5 |
—
|
no change | no change |
P
S
|
10,200 | $274,176 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MCRB
SERES THERAPEUT...
|
Healthcare | 1.19% | 1.67% |
#29
3
Prev: #26
|
1.5 |
—
|
no change | no change |
P
S
|
31,570 | $249,087 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AZTA
AZENTA INC
|
Healthcare | 1.18% | 1.22% |
#30
Prev: #30
|
1.5 |
—
|
no change | no change |
P
S
|
9,700 | $247,544 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JSPR
JASPER THERAPEU...
|
Healthcare | 0.94% | 2.44% |
#31
15
Prev: #16
|
1.4 |
—
|
no change | no change |
P
S
|
465,000 | $195,765 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INVA
INNOVIVA INC
|
Healthcare | 0.89% | 1.14% |
#32
1
Prev: #31
|
1.4 |
—
|
no change | no change |
P
S
|
8,200 | $186,222 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IPHA
INNATE PHARMA S...
|
Healthcare | 0.71% | 0.62% |
#33
1
Prev: #34
|
1.3 |
—
|
no change | no change |
P
S
|
81,151 | $149,318 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.66% | 0.74% |
#34
1
Prev: #33
|
1.3 |
—
|
no change | no change |
P
S
|
5,250 | $137,655 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SPRB
SPRUCE BIOSCIEN...
|
Healthcare | 0.26% | 0.39% |
#35
Prev: #35
|
1.1 |
—
|
no change | no change |
P
S
|
1,000 | $54,000 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-35 of 35 holdings